Cargando…
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
Background: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. Methods: We evaluate the effect of coff...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698499/ https://www.ncbi.nlm.nih.gov/pubmed/33213035 http://dx.doi.org/10.3390/jcm9113691 |
_version_ | 1783615845408178176 |
---|---|
author | Belaroussi, Yaniss Roblot, Paul Peiffer-Smadja, Nathan Delaye, Thomas Mathoulin-Pelissier, Simone Lemeux, Joffrey Le Moal, Gwenaël Caumes, Eric Roblot, France Bleibtreu, Alexandre |
author_facet | Belaroussi, Yaniss Roblot, Paul Peiffer-Smadja, Nathan Delaye, Thomas Mathoulin-Pelissier, Simone Lemeux, Joffrey Le Moal, Gwenaël Caumes, Eric Roblot, France Bleibtreu, Alexandre |
author_sort | Belaroussi, Yaniss |
collection | PubMed |
description | Background: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. Methods: We evaluate the effect of coffee’s active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. Results: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). Conclusions: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742. |
format | Online Article Text |
id | pubmed-7698499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76984992020-11-29 Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? Belaroussi, Yaniss Roblot, Paul Peiffer-Smadja, Nathan Delaye, Thomas Mathoulin-Pelissier, Simone Lemeux, Joffrey Le Moal, Gwenaël Caumes, Eric Roblot, France Bleibtreu, Alexandre J Clin Med Article Background: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. Methods: We evaluate the effect of coffee’s active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. Results: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). Conclusions: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742. MDPI 2020-11-17 /pmc/articles/PMC7698499/ /pubmed/33213035 http://dx.doi.org/10.3390/jcm9113691 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Belaroussi, Yaniss Roblot, Paul Peiffer-Smadja, Nathan Delaye, Thomas Mathoulin-Pelissier, Simone Lemeux, Joffrey Le Moal, Gwenaël Caumes, Eric Roblot, France Bleibtreu, Alexandre Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? |
title | Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? |
title_full | Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? |
title_fullStr | Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? |
title_full_unstemmed | Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? |
title_short | Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? |
title_sort | why methodology is important: coffee as a candidate treatment for covid-19? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698499/ https://www.ncbi.nlm.nih.gov/pubmed/33213035 http://dx.doi.org/10.3390/jcm9113691 |
work_keys_str_mv | AT belaroussiyaniss whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT roblotpaul whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT peiffersmadjanathan whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT delayethomas whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT mathoulinpelissiersimone whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT lemeuxjoffrey whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT lemoalgwenael whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT caumeseric whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT roblotfrance whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 AT bleibtreualexandre whymethodologyisimportantcoffeeasacandidatetreatmentforcovid19 |